Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders

Clinical trials for Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders explained in plain language.

Never miss a new study

Get alerted when new Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders trials appear

Sign up with your email to follow new studies for Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1

Genetic clues may forecast multiple sclerosis after vision loss

Knowledge-focused Not yet recruiting

This observational study looks at whether combining genetic information with standard clinical data can better predict who will develop multiple sclerosis after a first episode of optic neuritis (inflammation of the optic nerve). Researchers will follow 180 people aged 16 and old…

Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS

Sponsor: King's College London • Aim: Knowledge-focused

Last updated Jul 17, 2026 00:00 UTC

Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders

Get alerted when new Myelin oligodendrocyte glycoprotein (MOG)-antibody related disorders trials appear

Genetic clues may forecast multiple sclerosis after vision loss